Teveten (eprosartan), a new angiotensin II receptor blocker (ARB)
January 2001
Solvay is now marketing Teveten (eprosartan), a new angiotensin II receptor blocker (ARB).
Teveten will be used for mild to moderate hypertension...alone or in combination with a diuretic.
ARBs work as well as ACE inhibitors for hypertension. Plus they're better tolerated...less cough, angioedema, etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive